Diagnose this case. 27-year-old male. Presented with... Lower abdominal pain which is started... After 30 minutes of ejaculation. Severe in nature or very sharp? Radiate to tip of penis? End scrotum. There is no other... This is... And... Normal CBC, normal urine culture. Whole abdomen USG was normal. Scrotal USG is normal. No Pancreatitis. No per-- prostate enlargement or anything. Normal... Mektürating ses tuğruthurgram. Normal. Retrograde urethrogram. Means potent urethra. Diagon into the bladder.
Reading File
Finding Sources
Finding Sources
Searching PubMed
post-orgasmic pain syndrome
Reading File
Finding Sources
Reading File
Diagnosis: Painful Ejaculation (Odynorgasmia) — most likely due to Chronic Pelvic Pain Syndrome (CP/CPPS, Category IIIb / pelvic floor origin)
Why this fits
The clinical picture — a young man with sharp lower abdominal pain beginning ~30 minutes after ejaculation, radiating to the tip of the penis and scrotum, with a completely negative workup — matches the described entity of "Painful ejaculation" (odynorgasmia) in urology (Campbell-Walsh Urology, "Painful Ejaculation," p. 2099):
"Painful ejaculation or odynorgasmia is a poorly characterized syndrome. It may be associated with urethritis, BPH, acute or chronic prostatitis, chronic pelvic pain syndrome, seminal vesiculitis, seminal vesicular calculi, or ejaculatory duct obstruction... Often, no obvious etiologic factor can be found." - Campbell-Walsh Urology, p. 2099
His negative work-up is essentially a systematic exclusion of every organic cause on that list:
| Cause considered | Ruled out by |
|---|---|
| UTI / urethritis / prostatitis (bacterial) | Normal CBC, normal urine culture |
| Testicular/epididymal pathology, varicocele, torsion-related pain | Normal scrotal USG |
| BPH / prostatic enlargement | No prostate enlargement on imaging |
| Seminal vesiculitis, seminal vesicle calculi, ejaculatory duct obstruction | Whole abdomen USG normal (though TRUS is more sensitive for this specifically) |
| Bladder pathology, reflux | Normal micturating cystourethrogram (MCUG) |
| Urethral stricture / false passage / diverticulum | Normal retrograde urethrogram - patent urethra draining freely into the bladder |
| Pancreatitis (as a cause of referred abdominal pain) | Excluded clinically/biochemically |
Once infection, obstruction, structural urethral disease, and reproductive-organ pathology are all excluded, the working diagnosis becomes idiopathic post-ejaculatory pain, which in most modern series is attributed to CP/CPPS (NIH Category III) — pelvic floor muscle (levator ani/bulbospongiosus) spasm and/or pudendal nerve irritation triggered by the muscular contractions of ejaculation, rather than a structural lesion. Studies cited in Campbell-Walsh note this symptom is common in CPPS and can occur even when prostate size/imaging is normal.
Key differential to distinguish clearly
- Post-Orgasmic Illness Syndrome (POIS) - also begins within ~30 minutes of orgasm, but presents with systemic flu-like symptoms (severe myalgia, fatigue, malaise), not localized genital/abdominal pain. Your patient's pain is anatomically localized (lower abdomen -> penile tip -> scrotum), which argues against POIS and for local odynorgasmia/CPPS instead.
- Seminal vesiculitis / ejaculatory duct obstruction / seminal vesicle calculi - classically present this way, but transabdominal USG has limited sensitivity; if suspicion remains high, TRUS (transrectal ultrasound) with seminal vesicle assessment is the next best step, not yet excluded by the imaging described.
- Chronic prostatitis (Category IIIa/IIIb CPPS) - even with a normal-sized prostate, this remains the leading functional diagnosis; a focused digital rectal exam plus symptom scoring (NIH-CPSI) would support it.
Suggested next steps if further workup is wanted
- Digital rectal exam + prostatic massage for expressed prostatic secretions (to formally split Category IIIa from IIIb)
- NIH-CPSI questionnaire
- TRUS to specifically evaluate the seminal vesicles/ejaculatory ducts if not already done
- Trial of an alpha-blocker (uroselective, e.g., alfuzosin/tamsulosin) or pelvic floor physiotherapy, which are first-line for CPPS-associated post-ejaculatory pain
Evidence check
A quick recent-literature check (2017-2025 reviews) on "post-orgasmic illness syndrome" confirms it is a distinct, poorly understood entity from odynorgasmia/CPPS-related painful ejaculation - useful to keep separate in your differential (PMIDs: 39931017, 32033716, 29128269). No systematic review/meta-analysis in the last 2 years contradicts the CP/CPPS-based explanation for isolated post-ejaculatory genital pain with negative imaging.
Bottom line: With this exhaustive negative workup, the most defensible diagnosis is primary/idiopathic painful ejaculation (odynorgasmia), most consistent with Chronic Pelvic Pain Syndrome (CP/CPPS) - a diagnosis of exclusion once infective, structural, obstructive, and neoplastic causes are ruled out, as has been done here.
what should be next step
Finding Sources
Finding Sources
Searching PubMed
"chronic pelvic pain syndrome" AND treatment
Reading File
Next Steps
Since organic/structural causes have been systematically excluded, this is now confirmed primary/idiopathic painful ejaculation, best framed as CP/CPPS (Category IIIb). Management proceeds in two tracks: close the small remaining diagnostic gaps, then start a phenotype-directed multimodal treatment trial (per the 2025 AUA Guideline on CP/CPPS treatment, PMID 40243102 - evidence tier 1).
1. Close remaining diagnostic gaps (before labeling it purely functional)
- TRUS (transrectal ultrasound) with seminal vesicle/ejaculatory duct assessment — transabdominal USG has limited sensitivity for seminal vesiculitis, seminal vesicle calculi, and ejaculatory duct obstruction, which are the organic mimics still not formally excluded (Campbell-Walsh, p. 2099).
- Digital rectal exam + prostatic massage for expressed prostatic secretions (EPS) — needed to split NIH Category IIIa (inflammatory, WBCs in EPS/semen/post-massage urine) from IIIb (non-inflammatory) - this changes whether antibiotics are worth trialing (Campbell-Walsh, Box 56.1).
- NIH-CPSI questionnaire — quantifies pain, urinary, and quality-of-life domains; gives a baseline to track response to treatment.
- Focused history/exam for pelvic floor and psychosocial contributors per Box 56.1: pain pattern with bladder filling/emptying, bowel symptoms, neurologic red flags, anxiety/depression, pain worsened by stress, and a pelvic floor muscle exam (levator ani tenderness/spasm is often the driver of post-ejaculatory pain).
2. Empiric multimodal treatment (UPOINT-style, phenotype-directed)
Guided by the mandatory evaluation above, reasonable first-line options include:
- Alpha-blocker trial (e.g., tamsulosin or alfuzosin) — most evidence-backed pharmacologic option, especially if any voiding symptoms are present; alfuzosin specifically has a lower rate of ejaculatory pain as a side effect versus other alpha-blockers.
- Pelvic floor physical therapy / myofascial release — strongest evidence for cases where exam shows pelvic floor muscle tenderness/spasm (a randomized multicenter trial showed benefit specifically for this phenotype - Campbell-Walsh references).
- NSAIDs / anti-inflammatories for symptomatic pain control during flares.
- Antibiotic trial is only justified if EPS/urine shows inflammatory signs (Category IIIa) - placebo-controlled trials show no consistent benefit in Category IIIb, so I would NOT start empiric antibiotics in this patient given the already-normal urine culture.
- Psychological support / CBT if stress, anxiety, or pain catastrophizing is contributing (systematic review evidence, PMID 35938980).
- Reassurance and patient education are important in their own right — many men with this diagnosis do well once organic pathology is confidently excluded and they understand the benign, non-progressive nature of the condition.
3. If refractory
- Reassess with repeat NIH-CPSI at 6 weeks.
- Consider referral to a chronic pelvic pain / urology-physiotherapy clinic.
- Second-line/refractory options with growing evidence: extracorporeal shockwave therapy (meta-analysis, PMID 38847290), neuromodulation (systematic review, PMID 37726930), or repetitive transcranial magnetic stimulation (scoping review, PMID 40083455) - reserve these for cases not responding to first-line measures.
Bottom line for the very next visit: do a DRE with EPS analysis + NIH-CPSI scoring + pelvic floor exam, and consider TRUS to seal off the seminal vesicle/ejaculatory duct differential. Then start an alpha-blocker + pelvic floor physiotherapy trial based on exam findings, rather than further imaging or empiric antibiotics.
This is a shared conversation. Sign in to Orris to start your own chat.